X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Biocon Ltd with Cadila Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs CADILA HEALTHCARE - Comparison Results

BIOCON      Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON CADILA HEALTHCARE BIOCON /
CADILA HEALTHCARE
 
P/E (TTM) x 17.6 12.7 138.3% View Chart
P/BV x 2.8 2.7 104.1% View Chart
Dividend Yield % 0.4 1.5 27.2%  

Financials

 BIOCON    CADILA HEALTHCARE
EQUITY SHARE DATA
    BIOCON
Mar-18
CADILA HEALTHCARE
Mar-18
BIOCON /
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs1,188558 212.9%   
Low Rs305362 84.4%   
Sales per share (Unadj.) Rs68.7116.3 59.1%  
Earnings per share (Unadj.) Rs7.617.9 42.3%  
Cash flow per share (Unadj.) Rs14.023.1 60.4%  
Dividends per share (Unadj.) Rs1.003.50 28.6%  
Dividend yield (eoy) %0.10.8 17.6%  
Book value per share (Unadj.) Rs86.385.4 101.1%  
Shares outstanding (eoy) m600.001,023.74 58.6%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x10.94.0 274.8%   
Avg P/E ratio x98.925.7 384.2%  
P/CF ratio (eoy) x53.419.9 268.8%  
Price / Book Value ratio x8.65.4 160.6%  
Dividend payout %13.219.6 67.6%   
Avg Mkt Cap Rs m447,900470,664 95.2%   
No. of employees `0006.111.8 52.0%   
Total wages/salary Rs m9,31118,545 50.2%   
Avg. sales/employee Rs Th6,705.810,072.7 66.6%   
Avg. wages/employee Rs Th1,514.21,569.1 96.5%   
Avg. net profit/employee Rs Th736.91,547.7 47.6%   
INCOME DATA
Net Sales Rs m41,234119,049 34.6%  
Other income Rs m2,0621,132 182.2%   
Total revenues Rs m43,296120,181 36.0%   
Gross profit Rs m8,29128,475 29.1%  
Depreciation Rs m3,8515,388 71.5%   
Interest Rs m615911 67.5%   
Profit before tax Rs m5,88723,308 25.3%   
Minority Interest Rs m213628 33.9%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5695,644 27.8%   
Profit after tax Rs m4,53118,292 24.8%  
Gross profit margin %20.123.9 84.1%  
Effective tax rate %26.724.2 110.1%   
Net profit margin %11.015.4 71.5%  
BALANCE SHEET DATA
Current assets Rs m41,48682,005 50.6%   
Current liabilities Rs m21,41360,720 35.3%   
Net working cap to sales %48.717.9 272.3%  
Current ratio x1.91.4 143.5%  
Inventory Days Days6473 87.5%  
Debtors Days Days9498 95.8%  
Net fixed assets Rs m50,66183,703 60.5%   
Share capital Rs m3,0001,024 293.0%   
"Free" reserves Rs m48,80886,421 56.5%   
Net worth Rs m51,80887,445 59.2%   
Long term debt Rs m17,89825,551 70.0%   
Total assets Rs m99,897180,653 55.3%  
Interest coverage x10.626.6 39.8%   
Debt to equity ratio x0.30.3 118.2%  
Sales to assets ratio x0.40.7 62.6%   
Return on assets %5.210.6 48.5%  
Return on equity %8.720.9 41.8%  
Return on capital %9.622.0 43.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m12,05842,683 28.3%   
Fx outflow Rs m7,34811,242 65.4%   
Net fx Rs m4,71031,441 15.0%   
CASH FLOW
From Operations Rs m6,6219,193 72.0%  
From Investments Rs m-6,840-9,737 70.2%  
From Financial Activity Rs m-2,397515 -465.4%  
Net Cashflow Rs m-2,612-29 9,006.9%  

Share Holding

Indian Promoters % 40.4 74.8 54.0%  
Foreign collaborators % 20.6 0.0 -  
Indian inst/Mut Fund % 8.4 8.3 101.2%  
FIIs % 10.7 5.9 181.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 11.0 180.9%  
Shareholders   109,995 44,069 249.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   STERLING BIOTECH  SANOFI INDIA  ALEMBIC PHARMA  ORCHID PHARMA LTD  NOVARTIS  

Compare BIOCON With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Yes Bank's Road Ahead(Podcast)

The stock markets witnessed selling pressure in the week gone by. Market participants remained cautious tracking tepid quarterly earnings amid weak cues.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 21.0% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 21.0% YoY). Sales on the other hand came in at Rs 37 bn (up 14.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

BIOCON Announces Quarterly Results (4QFY19); Net Profit Down 53.8% (Quarterly Result Update)

Apr 26, 2019 | Updated on Apr 26, 2019

For the quarter ended March 2019, BIOCON has posted a net profit of Rs 705 m (down 53.8% YoY). Sales on the other hand came in at Rs 8 bn (down 34.7% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

BIOCON LTD Announces Quarterly Results (3QFY19); Net Profit Up 169.2% (Quarterly Result Update)

Jan 28, 2019 | Updated on Jan 28, 2019

For the quarter ended December 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 169.2% YoY). Sales on the other hand came in at Rs 15 bn (up 45.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

BIOCON LTD Announces Quarterly Results (2QFY19); Net Profit Up 501.9% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, BIOCON LTD has posted a net profit of Rs 4 bn (up 501.9% YoY). Sales on the other hand came in at Rs 13 bn (up 36.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Here's What to Do with Falling Small Cap Stocks(Profit Hunter)

Jul 10, 2019

There are some great buying opportunities in the market right now - and the small cap space is your best bet.

Budget an Icing on the Cake for This Smart Money Backed Affordable Housing Stock(The 5 Minute Wrapup)

Jul 10, 2019

Affordable housing is one of the most straightforward growth stories in India. This will help the real estate sector to come out of the slump.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


Jul 19, 2019 (Close)

TRACK BIOCON

COMPARE BIOCON WITH

MARKET STATS